Insulin glargine: long-acting basal insulin analog for improved metabolic control
- 1 January 2004
- journal article
- review article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 20 (1), 31-37
- https://doi.org/10.1185/030079903125002711
Abstract
The primary aim of insulin therapy is to replace endogenous insulin secretion in patients with type 1 or type 2 diabetes in a physiologically sound manner, mimicking normal secretion patterns to adequately regulate glucose metabolism. The currently available human insulins for basal therapy--neutral protamine Hagedorn (NPH), Lente and Ultralente--and analogs such as insulin glargine, differ in pharmacokinetic properties. Clinical trial data indicate that insulin glargine may satisfy basal insulin requirements, with an improved safety profile relative to other available insulins used for basal supplementation. This review describes the unique pharmacokinetic properties and clinical efficacy of insulin glargine.Keywords
This publication has 17 references indexed in Scilit:
- Hypoglycemia and Insulin Analogues:: Is There a Reduction in the Incidence?Journal of Diabetes and its Complications, 1999
- Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.Diabetes Care, 1999
- Use of the short-acting insulin analogue lispro in intensive treatment of Type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-mealDiabetic Medicine, 1998
- INTENSIVE TREATMENT OF TYPE 1 DIABETESMedical Clinics of North America, 1998
- Mealtime Treatment With Insulin Analog Improves Postprandial Hyperglycemia and Hypoglycemia in Patients With Non-Insulin-Dependent Diabetes MellitusArchives of Internal Medicine, 1997
- Monomeric Insulins and Their Experimental and Clinical ImplicationsDiabetes Care, 1990
- The Physiologic Replacement of InsulinNew England Journal of Medicine, 1989
- Demonstration of a Dawn Phenomenon in Normal Human VolunteersDiabetes, 1984
- Glucose Counterregulation and Waning of Insulin in the Somogyi Phenomenon (Posthypoglycemic Hyperglycemia)New England Journal of Medicine, 1984
- Control of Blood Sugar in Insulin-Dependent Diabetes: Comparison of an Artificial Endocrine Pancreas, Continuous Subcutaneous Insulin Infusion, and Intensified Conventional Insulin TherapyNew England Journal of Medicine, 1980